Kineta Inc.

OTC: KANT
Share price (1/6/25): $0.42
Market cap (1/6/25): $5.151 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Removal from listing

Prospectus supplement

Shelf registration

Exempt offering of securities

Prospectus supplement for primary offering

Ownership Filter

Armistice Capital, LLC

News Filter

TuHURA Biosciences, Inc. Enters Into Definitive Merger Agreement to Acquire Kineta, Inc

TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update

Updates KVA12123 Clinical Results From Ongoing Phase 1/2 VISTA101 Study at Society for Immunotherapy of Cancer

Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors

Announces KVA12123 Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness